EXACTLY!
There are good reasons for fixed price/fixed unit price agreements other
than clinical trials in some circumstances, particularly research with
for-profit sponsors. Projects of this nature are less likely to draw UBIT
attention than clinical trials. But consistent "surpluses" always "smell"
like UBIT.
Chuck
At 03:55 PM 10/31/2003, you wrote:
>** High Priority **
>
>Plus you get into UBI and here comes the IRS.
>
>Mary Spijkerman
>
> >>> xxxxxx@VCU.EDU 10/31/03 02:04PM >>>
>Yes, "you know it when you see it". A look at the actual charges will
>usually pretty clearly indicate if the PI has failed to charge to this
>project costs that reasonably apply to it. A big giveaway is no PI effort,
>or way too little effort. You have to watch out for the researcher who
>charged real costs of this project somewhere else, in order to build up a
>nest egg. Your policy of who gets the surplus and how it may be used might
>affect people's behavior in this arena.
>
>And carefully consider if the project was agreed to at less than full F&A;
>if so, you may want a policy that takes the F&A difference off the residual
>before making it available for other research and education uses.
>
>Having a little surplus indicates good, conservative budgeting. Having
>lots, especially if it is consistent, suggests making a "profit", which a
>non-profit should not consistently do.
>
>Chuck
>
>
>At 02:05 PM 10/31/2003, Doug Wilkerson wrote:
> >How much Residual is too much??? After your PI certifies that he/she has
> >paid all internal and external bills (and you verify this however you can)
> >and you have a "release" from the sponsoring company saying that they are
> >satisfied that you have delivered everything that you promised, what
> >percentage of the revenues would you expect (and be comfortable with)
> >being left in the study account? Is 10% OK? How about 30%? How about
> >70%? OR, is too much like pornography "you know it when you see it"?
> >
> >
> >
> >
> >Doug Wilkerson, Ph.D. Phone: (419) 383-4252
> >Assoc. Vice Pres. for Research Fax: (419) 383-4262
> >Professor of Pharmacology E-mail: xxxxxx@mco.edu
> >Research & Grants Admin. Web: www.mco.edu/research
> >Block Health Sci. Bldg., Rm. 148
> >3035 Arlington Ave.
> >Toledo, OH 43614-5804
> >
> >
> >======================================================================
> > Instructions on how to use the RESADM-L Mailing List, including
> > subscription information and a web-searchable archive, are available
> > via our web site at http://www.hrinet.org (click on "Listserv Lists")
> >======================================================================
>
>Herbert B. Chermside, CRA
>Director, Sponsored Programs Administration
>Virginia Commonwealth University
>PO BOX 980568
>Richmond, VA 23298-0568
>Express Delivery Only:
> Biotech One, Suite 113
> Virginia Biotechnology Research Park
> 800 East Leigh Street
> Richmond, VA 23219
>Voice: 804-828-6772
>Fax 804-828-2521
>OFFICE e-mail xxxxxx@VCU.EDU
>Personal e-mail xxxxxx@vcu.edu
>http://www.research.vcu.edu/ospa.htm
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
Herbert B. Chermside, CRA
Director, Sponsored Programs Administration
Virginia Commonwealth University
PO BOX 980568
Richmond, VA 23298-0568
Express Delivery Only:
Biotech One, Suite 113
Virginia Biotechnology Research Park
800 East Leigh Street
Richmond, VA 23219
Voice: 804-828-6772
Fax 804-828-2521
OFFICE e-mail xxxxxx@VCU.EDU
Personal e-mail xxxxxx@vcu.edu
http://www.research.vcu.edu/ospa.htm
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
